Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2070]

Predicting disease recurrence in patients with early triple-negative breast...

Dr Milan Radovich - Indiana University Melvin and Bren Simon Cancer Center...

Predicting disease recurrence in patients with early triple-negative breast cancer using circulating tumour DNA ( Dr Milan Radovich - Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, USA )

FLT3-inhibition in infants with acute lymphoblastic leukaemia

Dr Patrick Brown - Johns Hopkins University, Baltimore, USA

FLT3-inhibition in infants with acute lymphoblastic leukaemia ( Dr Patrick Brown - Johns Hopkins University, Baltimore, USA )

Study of quadruple combination for induction resistant myeloma reveals novel...

Dr Yael Cohen - Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

Study of quadruple combination for induction resistant myeloma reveals novel immune checkpoints ( Dr Yael Cohen - Tel Aviv Sourasky Medical Center, Tel Aviv, Israel )

Identifying prognostic constellations of driver mutations in acute myeloid...

Dr Charles Mullighan - St. Jude Children's Research Hospital, Memphis, USA

Identifying prognostic constellations of driver mutations in acute myeloid leukaemia and myelodysplastic syndromes ( Dr Charles Mullighan - St. Jude Children's Research Hospital, Memphis, USA )

Exploring the pathogenesis of AML and myelodysplastic syndromes using genome...

Dr Ilaria Iacobucci - St. Jude Children's Research Hospital, Memphis, USA

Exploring the pathogenesis of AML and myelodysplastic syndromes using genome and transcriptome sequencing ( Dr Ilaria Iacobucci - St. Jude Children's Research Hospital, Memphis, USA )

Multiple myeloma: Anti-BCMA BiTE AMG 701 shows preclinical promise

Dr Yu-Tzu Tai - Dana-Farber Cancer Institute, Boston, USA

Multiple myeloma: Anti-BCMA BiTE AMG 701 shows preclinical promise ( Dr Yu-Tzu Tai - Dana-Farber Cancer Institute, Boston, USA )

PROfound: PARP inhibitor olaparib compared with new hormonal agents in advanced...

Prof Maha Hussain - Northwestern University Feinberg School of Medicine...

PROfound: PARP inhibitor olaparib compared with new hormonal agents in advanced castration resistant prostate cancer ( Prof Maha Hussain - Northwestern University Feinberg School of Medicine, Chicago, USA )

Analysis of assay used in IMpassion130 to guide treatment of metastatic and...

Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia

Analysis of assay used in IMpassion130 to guide treatment of metastatic and advanced breast cancers ( Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia )

Rectal cancer in Latin America, screening and surgery

Dr. Nitin Mishra - Mayo Clinic, Rochester, USA

Rectal cancer in Latin America, screening and surgery ( Dr. Nitin Mishra - Mayo Clinic, Rochester, USA )

The challenge of detecting NTRK fusions across tumour types

Professor Dr Marc Peeters, Professor Caterina Marchio

The challenge of detecting NTRK fusions across tumour types ( Professor Dr Marc Peeters, Professor Caterina Marchio )

Simplifying molecular subtypes of metastatic gastric cancer

Dr Maria Alsina - Vall d'Hebron Instituto de Oncología (VHIO), Barcelona, Spain

Simplifying molecular subtypes of metastatic gastric cancer ( Dr Maria Alsina - Vall d'Hebron Instituto de Oncología (VHIO), Barcelona, Spain )

PROMISE-meso trial results: Pembrolizumab vs chemotherapy for advanced pleural...

Prof Sanjay Popat - The Royal Marsden Hospital, London, UK

PROMISE-meso trial results: Pembrolizumab vs chemotherapy for advanced pleural mesothelioma ( Prof Sanjay Popat - The Royal Marsden Hospital, London, UK )

More from ecancer